67735-60-8

Usage

Uses

Used in Organic Synthesis:
1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE is used as an intermediate in the synthesis of various organic products, contributing to the creation of a wide array of chemical compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE is utilized as a key intermediate for the development of new drugs, playing a crucial role in advancing medicinal chemistry.
Used in Drug Development:
1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE is employed as a building block in the construction of complex organic molecules, which are essential for the formulation of innovative pharmaceuticals.
Used in Antioxidant Applications:
Due to its potential antioxidant properties, 1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE is used in applications that require protection against oxidative stress, which is beneficial in various chemical and biological processes.
Used in Antimicrobial Applications:
Leveraging its antimicrobial properties, 1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBALDEHYDE is applied in contexts where inhibition of microbial growth is necessary, such as in the development of antimicrobial agents and preservatives.

InChI:InChI=1/C11H9NO2/c1-12-10-5-3-2-4-8(10)6-9(7-13)11(12)14/h2-7H,1H3

Upstream product

• 91301-03-0 3-formyl-2-quinolone 
• 114561-16-9 3-bromomethyl-1-methyl-2-oxo-1,2-dihydroquinoline 
• 91301-03-0 2-hydroxyquinoline-3-carboxaldehyde 
• 74-88-4 methyl iodide 
• 73568-25-9 2-chloro-3-quinoline carboxaldehyde 
• 103-84-4 Acetanilid 
• 59050-15-6 ethyl 3-(N-methyl-N-phenylamino)-3-oxopropionate 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 1242422-63-4 C₂₀H₂₆N₂O 
• 1226998-24-8 3-({[2-(4,4-difluoropiperidin-1-yl)-2-phenylethyl]amino}methyl)-1-methylquinolin-2(1H)-one 
• 1226997-64-3 tert-butyl 4-(2-{[(1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)methyl]amino}-1-phenylethyl)piperidine-1-carboxylate 
• 1226997-55-2 1-methyl-3-({[2-phenyl-2-(tetrahydro-2H-pyran-4-yl)ethyl]amino}methyl)quinolin-2(1H)-one 
• 1226997-40-5 C₂₈H₃₆N₄O₃ 
• 1226998-01-1 3-{[(1-benzyl-3-methylpyrrolidin-3-yl)amino]methyl}-1-methylquinolin-2(1H)-one 
• 28448-08-0 3-cyano-1-methyl-2(1H)-quinolone 

Relevant academic research and scientific papers

CRBN LIGANDS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.

Triflic anhydride-mediated tandem formylation/cyclization of cyanoacetanilides: a concise synthesis of glycocitlone alkaloids

A method is presented for the concise synthesis of 3-formyl-4-hydroxyquinolin-2(1H)-ones through triflic anhydride-mediated tandem formylation/cyclization of cyanoacetanilides. This tandem process was successfully used for the rapid syntheses of glycocitl

HETEROCYCLIC ETHERS

The invention concerns a heterocyclic ether of the formula I wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms; A is (l-6C)alkylene, (3-6C)alkenylene, (3-6C)alkyny

Carbostyril derivatives

Disclosed are carbostyril derivatives and their salts of the formulas STR1 The compounds have anti-peptic ulcer effects, and are useful as a treating agent for curing peptic ulcers in the digestive system, such as ulcers in the stomach and in the duodenum. The compounds particularly have prophylaxis and curing effects for treating chronic ulcers, for example experimental acetic acid-induced ulcers and cautery ulcers, with both low toxicity and few side-effects. Also disclosed are processes for preparing the compounds and for preparing pharmaceutical compositions containing them.